The Tyranny of LDN (Low Dose Naltrexone) Aug 10. 2010 | Comments (4)
The case for politics in LDN.First, the systems that provide for research are unable to respond. The commercial sector needs profit which does not exist for LDN. The government NIHR etc requires applications from existing researchers or the pharmaceutical industry. These have been lacking for 30 years, so we can assume this source is cold too.So the systems for research are configured to fail to recognise a drug like LDN with no patent, no profit and a new medical paradigm for treating so many diseases.Second, because of the money involved and the need to change the systems to respond to pressure from patients who demand the research, we need the politicians to pass edicts that change things and make sure that a drug like LDN, with such large patient support, can get the research without competing for a ‘slot’ simply because the patients can choose for research to be commissioned. We as LDN users are saving over 100 million pounds a year in the NHS in the UK, and the same in...